Cytosorbents (CTSO) Other financing activities (2010 - 2025)

Cytosorbents (CTSO) has reported Other financing activities for 15 consecutive years, with $1.4 million the latest figure, recorded in Q1 2025.

• For the quarter ending Q1 2025, Other financing activities rose 2602.96% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (changed N/A YoY), and the FY2025 full-year result was $1.4 million, changed N/A from the prior year.
• Other financing activities climbed to $1.4 million in Q1 2025 per CTSO's latest filing, from $53238.0 in the prior quarter.
• Across five years, Other financing activities topped out at $1.4 million in Q1 2025 and bottomed at $4971.0 in Q4 2023.
• Historically, Other financing activities has averaged $251571.5 across 4 years, with a median of $64895.5 in 2021.
• The sharpest annual moves came in 2021 and 2025: Other financing activities plunged 99.57% in 2021, then surged 2602.96% in 2025.
• Over 4 years, Other financing activities stood at $9076.0 in 2021, then tumbled by 45.23% to $4971.0 in 2023, then jumped by 970.97% to $53238.0 in 2024, then soared by 2602.96% to $1.4 million in 2025.
• According to Business Quant data, Other financing activities over the past three periods registered $1.4 million, $53238.0, and $4971.0 for Q1 2025, Q1 2024, and Q4 2023 respectively.